| | | | |
CUSIP No. 704723105 | | Schedule 13G | | Page 6 of 10 |
ITEM 1. | (a) Name of Issuer: |
Pear Therapeutics, Inc. (the “Issuer”).
(b) Address of Issuer’s Principal Executive Offices:
200 State Street, 13th Floor, Boston, MA 02109.
ITEM 2. | (a) Name of Person Filing: |
Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:
SB Global Advisers Limited (“SBGA”)
SoftBank Vision Fund II-2 L.P.
SVF II Aggregator (Jersey) L.P.
SVF II Holdings (DE) LLC
SVF II Cobbler (DE) LLC
(b) Address or Principal Business Office:
The principal business address for SBGA is 69 Grosvenor Street, London W1K 3JP, United Kingdom. The principal business address for each of SoftBank Vision Fund II-2 L.P. and SVF II Aggregator (Jersey) L.P. is Crestbridge Limited, 47 Esplanade, St. Helier, Jersey, JE1 0BD. The principal business address for each of SVF II Holdings (DE) LLC and SVF II Cobbler (DE) LLC is 251 Little Falls Drive, Wilmington, DE 19808.
(c) Citizenship of each Reporting Person is:
SBGA is organized under the laws of England and Wales. Each of SoftBank Vision Fund II-2 L.P. and SVF II Aggregator (Jersey) L.P. is organized under the laws of Jersey. Each of SVF II Holdings (DE) LLC and SVF II Cobbler (DE) LLC is organized under the laws of the State of Delaware.
(d) Title of Class of Securities:
Class A common stock, par value $0.0001 per share (“Class A Common Stock”).
(e) CUSIP Number:
704723105